An insecticidal composition which comprises as an active ingredient a compound of the formula: ##STR1## wherein X is a hydrogen atom or an acyl group, Y is a hydrogen atom, a lower alkyl group or a halogen atom and R.sub.1 and R.sub.2, which may be the same or different, are each a hydrogen atom, a lower alkyl group, a cyclo(lower)alkyl group, a lower alkenyl group, a lower alkynyl group, a lower alkoxy group or an acyl group, provided that R.sub.1 and R.sub.2 are not simultaneously a hydrogen a...

There is provided use of a pectin composition to prepare an aqueous composition having high yield stress characteristics without substantial gelation, wherein the pectin composition comprises at least a population of pectin that is calcium sensitive; wherein the pectin composition is capable of imparting high yield stress characteristics to an aqueous composition without causing substantial gelatin of the aqueous composition. There is also provided a standardised acidic aqueous composition compr...

The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9' have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

A method of treating Attention Deficit Hyperactivity Disorder, Conduct Disorder and related disorders which comprises using the atypical antipychotic agent quetiapine.

The present invention relates to the use of diureides of dicarboxylic acids of the formula I ##STR1## in which R is hydrogen or SO.sub.2 O.sup..crclbar. M.sup..sym., M.sup..sym. is lithium, sodium, potassium, cesium, ammonium, copper, silver, 0.5 iron, 0.5 calcium, 0.5 magnesium, 0.5 manganese, 0.5 zinc or 0.5 cobalt and X is a saturated or monounsaturated, straight-chain or branched C.sub.1 - to C.sub.8 -alkyl which may be interrupted by oxygen or NH and which may have attached to it C.sub.1 - ...

The invention relates to the use of nootropics, particularly Piracetam.RTM., in connection with the treatment of cancer with cytostatically effective preparations, for the prevention or mitigation of side effects which are caused by cytostatics.

The present invention is concerned with compounds of formula I ##STR1## wherein Z, R.sup.1 and R.sup.2 are as defined herein, as well as their pharmaceutically acceptable salts as therapeutically active substances against central nervous system disorders and for the production of corresponding medicaments.

The present invention is concerned with compounds of formula ##STR1## wherein Z is a substituted indolyl group of formula ##STR2## R.sup.1 is hydrogen, amino, lower alkylamino, lower dialkylamino, lower alkyl, halogen, or trifluoromethyl; R.sup.2 is hydrogen or lower alkyl; R.sup.11 is hydrogen or halogen; R.sup.12 is hydrogen or lower alkyl; and a is a single or double bond; or a pharmaceutically acceptable salt.

A reduced shade paint or ink comprising (a) a base paint or ink comprising a base pigment such as titanium dioxide, a film-forming resin and a non-polar liquid such as white spirits; (b) one or more dispersant which is a phosphate ester of a compound of formula 1 ##STR1## wherein Y is a group RO-- or a group H--(EO).sub.q --; R is C.sub.1-10 -alkyl; m and q are each, independently, from 5 to 50; n is from 5 to 70; and (c) a tinter composition comprising a colored pigment, water and/or a water-mi...

Tripeptides composed of the amino acids glycine, leucine, and phenylalanine or tyrosine obtainable by fractionation of hydrolysis products of human casein or by direct synthesis can be used as immunostimulants.